Sorafenib-resistant HCC cell line PLC/PRF/5 was established (PLC/PRF/5SorR mutant cell pool) and used to identify potential candidate genes for drug resistance by analyzing the differentially expressed gene (DEG) profiling by RNA-seq. Here, HSPG2 is linked to hepatocellular carcinoma.